Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

RTTNews | il y a 1150
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.

HT-TBI is being developed as a novel, point-of-care therapy for the treatment and/or prevention of secondary brain injury resulting from ischemic stroke and traumatic brain injury (TBI).

HT-TBI will be developed as a ready-to-use drug-device combination product for use in non-healthcare settings by patients and caregivers at risk for stroke/TBI, emergency healthcare professionals, and military personnel.

The HT-TBI formulation development and manufacturing work by Altasciences will be used to support a future Investigational New Drug (IND) Application to initiate clinical trials.

For More Such Health News, visit rttnews.com

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | il y a 794
Disney Q4 Profit Beats Street, Revenues Miss; Sees Adj. EPS Growth, Plans $7 Bln Buyback; Stock Down

Disney Q4 Profit Beats Street, Revenues Miss; Sees Adj. EPS Growth, Plans $7 Bln Buyback; Stock Down

Shares of Walt Disney Co. were losing around 4 percent in the pre-market activity on Thursday after the media and entertainment major reported nearly flat revenues in its fourth quarter below market estimates, even though profit beat the Street. Further, the firm said it expects double digit year-over-year growth in adjusted earnings per share for fiscal 2026 and 2027, and targets doubling share
RTTNews | il y a 1h 5min
UK Economy Logs Marginal Growth

UK Economy Logs Marginal Growth

The UK economy logged only a marginal growth in third quarter as the cyber attack on Jaguar Land Rover hit production, official data revealed on Thursday. Gross domestic product grew 0.1 percent sequentially, following the prior quarter's 0.3 percent expansion, the Office for National Statistics reported Thursday. Output was expected to advance 0.2 percent.
RTTNews | il y a 1h 48min
CAC 40 Rises 0.5%; Bank, Luxury Stocks Shine

CAC 40 Rises 0.5%; Bank, Luxury Stocks Shine

France's CAC 40 rose to a record high Thursday morning as stocks climbed higher, reacting to U.S. President Donald Trump signing a bill to end the longest government shutdown in history. Expectations of an interest rate cut by the Federal Reserve next month contribute as well to market's positive move.
RTTNews | il y a 2h 31min
DAX Retreats After Positive Start, Down Nearly 0.5%

DAX Retreats After Positive Start, Down Nearly 0.5%

German stocks are swinging between gains and losses in cautious trade on Thursday with investors digesting the news about U.S. President Donald Trump signing the short-term funding bill that brings an end to the government shutdown, and looking ahead to some key U.S. economic data.
RTTNews | il y a 2h 52min